New Report Calls For Collective Action to Combat Asia's Growing Antimicrobial Resistance Threat

credit:

Report outlines four high-impact intervention areas from education and prevention to surveillance and treatment to guide funders and partners.

AMR could cost Asia up to US$700 billion by 2050 and surpass cancer as the world's leading cause of death.

timely investment in AMR solutions could generate US$10 15 billion in annual healthcare savings, and cut annual socio-economic costs.

Read the Entire Article

A customized collection of grant news from foundations and the federal government from around the Web.